Enveric Biosciences, Inc. (ENVB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
4851 Tamiami Trail North
Naples, FL 34103
United States of America (the)
Phone
239 302 1707
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
May 04, 2015
| Name | Title | Pay | Year Born |
| Joseph Edward Tucker | Chief Executive Officer & Director | 472,399 | 1969 |
| Peter J. Facchini | Chief Innovation Officer | 221,781 | 1964 |
| Kevin Coveney | Chief Financial Officer | 396,550 | 1964 |
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.